Chelsea and Westminster Hospital, London, UK.
Dermatological Surgery and Laser Unit, St John's Institute of Dermatology, Guy's Hospital Cancer Centre, Guy's and St Thomas NHS Foundation Trust, Great Maze Pond, London, UK.
Clin Exp Dermatol. 2018 Jul;43(5):513-517. doi: 10.1111/ced.13553. Epub 2018 May 17.
Intravenous immunoglobulin (IVIg) is a solution of human IgG, salt, sugars and solvents, which is used to treat a multitude of diseases. Although IVIg has been known to treat many diseases safely and successfully, there are relatively few supporting randomized controlled trials. In this article, we review the biological mechanisms of IVIg in dermatological disorders and the practicalities of its use, including its mechanism of action, dosing, availability, costs and adverse effects.
静脉注射免疫球蛋白（IVIg）是一种含有人类 IgG、盐、糖和溶剂的溶液，用于治疗多种疾病。尽管 IVIg 已被证明可以安全有效地治疗许多疾病，但支持其使用的随机对照试验相对较少。本文综述了 IVIg 在皮肤科疾病中的生物学机制及其实用性，包括其作用机制、剂量、可用性、成本和不良反应。
